|
January 19, 2008 : Financial Results
HIGHLIGHTS
1.
Q3 Income up 20%
(YoY).
2. Q3 Net Profit up by 10%
(YoY).
3. Nine months Income up 19%
(YoY).
4.
Nine months Net Profit up 25% (YoY).
Q3
FINANCIAL
RESULTS
The net total income for the 3rd quarter has gone up by 20% to
Rs.282.37 crores as against Rs.234.76 crores in the same period previous
financial year. Export Sales
have increased by 14% to Rs.141.43 crores.
The Net
Profit for the 3rd Quarter has increased by 10% to Rs.38.34
crores as against Rs.34.84 crores in the same period of previous year.
| 3rd Quarter at a glance |
| (Rs. Crores) |
| 3rd Quarter ended |
31.12.2007 |
31.12.2006 |
Growth |
| Net Total Income |
282.37 |
234.76 |
20% |
| Export Income
|
141.43 |
124.07 |
14% |
| Net Profit
|
38.34
|
34.84 |
10% |
| Diluted Earnings per share (Rs.)
|
15.23 |
13.90 |
10% |
| Nine months at a glance |
| (Rs. Crores) |
| Nine months ended | 31.12.2007 | 31.12.2006 | Growth |
| Net Total Income | 830.04 | 699.78 | 19% |
| Export Income
| 388.91 | 340.11 | 14% |
| Net Profit
| 118.48
| 94.58 | 25% |
| Diluted Earnings per share (Rs.)
| 47.07 | 37.74 | 25% |
Ipca Laboratories is a backward integrated, fast growing pharmaceutical major, with a strong thrust on exports. Exports to nearly 110 countries now account for nearly half of Company's income.
M. R. Chandurkar
Managing Director
| 
Home 
Search 